Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-23

Clinical Trial Update: Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing oral versus intravenous ibuprofen for treating patent ductus arteriosus in extremely premature infants, with current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (intravenous) (ibuprofen)
  • Ibuprofen (oral) (ibuprofen)

Snippet

Sponsor: China Medical University Hospital | Conditions: Extremely Premature Infants, PDA | Phase 1, Phase 2 | Status: UNKNOWN